Heart Failure Clinical Trial

Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients

Summary

Study Purpose and Rationale The purpose of this study is to evaluate the lung Doppler signals changes during cardiac resynchronization procedure. As the LDS represent the various mechanical events of cardiac origin it is assumed that they may reflect the relative timing between contraction of the ventricles and atria and thus serve for effective synchronization of these activities.

Aim of the study:

The aim of the study is to assess whether the changes in Lung Doppler Signal (LDS) waves' characteristics will mimic the changes in echocardiographic parameters designed to assess diastolic inflow and systolic flow in patients undergoing Echo-based CRT optimization.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male and female patients 18 years or older, who met the indications for cardiac synchronization therapy (CRT) per the ACCF/AHA guidelines, underwent successful system implant for more than 3 months, and were referred to the CRT non-responder clinic at the Ohio State University for CRT- Echo optimization due to absence of clinical improvement in functional class or ejection fraction after the implant per the judgment of the referring physician.

Exclusion Criteria:

Chronic atrial fibrillation or new cardiac arrhythmias detected at the time of the visit that are known to affect the response to CRT (Atrial fibrillation, supraventricular tachycardia, ventricular tachycardia, or frequent premature ventricular contractions).
CRT device malfunction
Inadequate CRT programming that has contributed to lack of response to CRT
Coronary sinus lead anatomical or electrical malfunctions at the time of the visit
Acute systemic illness that can explain their lack of functional improvement (i.e., anemia, severe electrolyte imbalance, pneumothorax, pericardial effusion, pneumonia)
Inability to sign informed consent

Study is for people with:

Heart Failure

Estimated Enrollment:

10

Study ID:

NCT02179203

Recruitment Status:

Completed

Sponsor:

Echosense Ltd.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

The Ohio State University 473 West 12th Ave.
Columbus Ohio, 43210, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

10

Study ID:

NCT02179203

Recruitment Status:

Completed

Sponsor:


Echosense Ltd.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider